Literature DB >> 24954263

Predictors for the development of progressive severity in new-onset adult asthma.

Guus A Westerhof1, Elise M Vollema2, Els J Weersink2, Susanne M Reinartz3, Selma B de Nijs2, Elisabeth H Bel2.   

Abstract

BACKGROUND: A proportion of patients with adult-onset asthma have severe disease. Risk factors for an increase in asthma severity are poorly known.
OBJECTIVE: We sought to identify predictors for the development of severe asthma in adults.
METHODS: A cohort of 200 adults with new-onset asthma was prospectively followed for 2 years. At baseline, patients underwent a comprehensive assessment of clinical, functional, and inflammatory parameters. After 2 years, change in asthma severity was assessed by using the Global Initiative for Asthma score (range, 1-4), which is based on asthma control (Asthma Control Questionnaire), lung function (FEV1), and inhaled corticosteroid requirement. ANOVA and multiple regression equations were used in the analysis.
RESULTS: One hundred twenty-eight patients completed 2 years of follow-up. Seventeen (13.3%) patients had an increase in asthma severity, whereas 53 (41.4%) patients had a decrease. A lower postbronchodilator FEV1/forced vital capacity ratio and a higher number of cigarette pack years smoked at baseline were significantly associated with an increase in asthma severity at follow-up. Multiple regression equations showed that only the number of cigarette pack years smoked was independently associated with an increase in asthma severity, with an odds ratio of 1.4 (95% CI, 1.02-1.91) for every 10 pack years smoked.
CONCLUSION: A history of cigarette smoking in patients with new-onset adult asthma predicts an increase in asthma severity during the first 2 years of the disease in a dose-dependent manner.
Copyright © 2014 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adult-onset asthma; asthma severity; new-onset asthma; predictors; prospective follow-up study; smoking

Mesh:

Year:  2014        PMID: 24954263     DOI: 10.1016/j.jaci.2014.05.005

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  7 in total

Review 1.  Eosinophilic and Noneosinophilic Asthma.

Authors:  Tara F Carr; Amir A Zeki; Monica Kraft
Journal:  Am J Respir Crit Care Med       Date:  2018-01-01       Impact factor: 21.405

2.  Seinäjoki Adult Asthma Study (SAAS): a protocol for a 12-year real-life follow-up study of new-onset asthma diagnosed at adult age and treated in primary and specialised care.

Authors:  Hannu Kankaanranta; Pinja Ilmarinen; Terhi Kankaanranta; Leena E Tuomisto
Journal:  NPJ Prim Care Respir Med       Date:  2015-06-25       Impact factor: 2.871

Review 3.  Late-onset asthma: current perspectives.

Authors:  Tsunahiko Hirano; Kazuto Matsunaga
Journal:  J Asthma Allergy       Date:  2018-02-09

4.  Association of asthma with coronary heart disease: A meta analysis of 11 trials.

Authors:  Lida Wang; Shuyan Gao; Mingdong Yu; Zhixin Sheng; Wei Tan
Journal:  PLoS One       Date:  2017-06-13       Impact factor: 3.240

5.  Proximity to Heavy Traffic Roads and Patient Characteristics of Late of Onset Asthma in an Urban Asthma Center.

Authors:  Ting-Yu Lin; Horng-Chyuan Lin; Yun-Sheng Liu; Yu-Lun Lo; Chun-Hua Wang; Po-Jui Chang; Chun-Yu Lo; Shu-Min Lin
Journal:  Front Med (Lausanne)       Date:  2021-12-16

6.  Determinants of Severe Asthma - A Long-Term Cohort Study in Northern Sweden.

Authors:  Helena Backman; Caroline Stridsman; Linnea Hedman; Lina Rönnebjerg; Bright I Nwaru; Thomas Sandström; Hannu Kankaanranta; Anne Lindberg; Eva Rönmark
Journal:  J Asthma Allergy       Date:  2022-10-10

Review 7.  Phenotypes, Risk Factors, and Mechanisms of Adult-Onset Asthma.

Authors:  Pinja Ilmarinen; Leena E Tuomisto; Hannu Kankaanranta
Journal:  Mediators Inflamm       Date:  2015-10-11       Impact factor: 4.711

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.